Technical Overview for Veterinary Diagnostic Applications:Dog Rabies Antigen Rapid Test Card

/ Main / By

Rabies is a fatal viral encephalitis caused by the Rabies virus, a negative-sense single-stranded RNA virus belonging to the genus Lyssavirus (family Rhabdoviridae). Comprehensive technical background on rabies virology is available through the U.S. Centers for Disease Control and Prevention (CDC):
https://www.cdc.gov/rabies/index.html

Additional molecular and epidemiological data are provided by the National Center for Biotechnology Information (NCBI):
https://www.ncbi.nlm.nih.gov/books/NBK448076/

The Dog Rabies Antigen Rapid Test Card is a lateral flow immunochromatographic assay (LFIA) developed for qualitative detection of rabies virus nucleoprotein antigen in canine tissue samples. It is intended for veterinary diagnostic screening, field surveillance, and research use.

Virological and Molecular Background

Rabies virus is an enveloped, bullet-shaped virion approximately 180 × 75 nm in dimension. The genome (~12 kb) encodes five structural proteins: N, P, M, G, and L. Detailed genomic structure and replication mechanisms are described by the National Institutes of Health (NIH):
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095390/

The nucleoprotein (N) is highly conserved and is the primary antigenic target in most antigen-detection assays. The CDC laboratory diagnostics overview describes antigen-based testing principles:
https://www.cdc.gov/rabies/diagnosis/index.html

The U.S. Department of Agriculture (USDA) also provides technical resources on rabies in domestic animals:
https://www.aphis.usda.gov/aphis/ourfocus/animalhealth/animal-disease-information/rabies

Principle of the Dog Rabies Antigen Rapid Test Card

The assay is based on lateral flow immunochromatography:

  1. Sample extraction buffer solubilizes viral antigens.

  2. Antigen binds to colloidal gold-conjugated monoclonal antibodies.

  3. The antigen–antibody complex migrates via capillary action.

  4. Immobilized anti-rabies antibodies at the test line capture the complex.

  5. A visible colored band indicates antigen presence.

Technical guidance on lateral flow assay principles can be reviewed via the U.S. Food & Drug Administration (FDA):
https://www.fda.gov/medical-devices/in-vitro-diagnostics/lateral-flow-assays

Immunochromatographic assay fundamentals are further explained by NIH resources:
https://www.ncbi.nlm.nih.gov/books/NBK555922/

AffiVET® Dog Rabies Antigen Rapid Test Card

Sample Type and Handling Considerations

Rabies antigen detection is typically performed on brain tissue (hippocampus, cerebellum, brainstem). CDC specimen handling guidance:
https://www.cdc.gov/rabies/exposure/animals/domestic.html

Laboratory biosafety practices are described by the U.S. Department of Health & Human Services (HHS):
https://www.hhs.gov/ohrp/sachrp-committee/recommendations/attachment-biosafety.html

NIH biosafety level (BSL) guidance:
https://www.niaid.nih.gov/research/biosafety-levels

The U.S. Geological Survey (USGS) provides wildlife rabies surveillance documentation:
https://www.usgs.gov/centers/nwhc/science/rabies

Comparison with Reference Diagnostic Methods

The gold standard laboratory method for rabies confirmation is the Direct Fluorescent Antibody (DFA) test. CDC DFA protocol reference:
https://www.cdc.gov/rabies/diagnosis/dfa.html

Additional confirmatory molecular methods such as RT-PCR are described in NIH publications:
https://pubmed.ncbi.nlm.nih.gov/30401785/

European Union reference laboratory standards:
https://food.ec.europa.eu/safety/biological-safety/food-borne-diseases/rabies_en

UK governmental rabies surveillance documentation:
https://www.gov.uk/guidance/rabies

Rapid antigen tests function as screening tools and do not replace laboratory confirmation where required by regulatory frameworks.

Epidemiological Context

Rabies remains enzootic in multiple regions globally. CDC epidemiological data:
https://www.cdc.gov/rabies/location/usa/surveillance/index.html

National Institute of Allergy and Infectious Diseases (NIAID) rabies research overview:
https://www.niaid.nih.gov/diseases-conditions/rabies

MedlinePlus (U.S. National Library of Medicine) clinical overview:
https://medlineplus.gov/rabies.html

World rabies burden estimates (U.S. government global health data portal):
https://www.cdc.gov/globalhealth/healthprotection/fieldupdates/winter-2019/rabies-elimination.html

Technical Specifications (General Characteristics)

  • Assay Type: Lateral Flow Immunochromatographic Assay

  • Target Antigen: Rabies virus nucleoprotein

  • Result Format: Visual colored line (qualitative)

  • Detection Window: Minutes

  • Storage Conditions: Typically 2–30°C (manufacturer dependent)

  • Intended Use: Veterinary diagnostic screening and surveillance

Analytical Performance Considerations

Performance parameters typically evaluated include:

  • Analytical sensitivity (limit of detection)

  • Analytical specificity

  • Cross-reactivity testing

  • Reproducibility

  • Interference studies

FDA in vitro diagnostic performance documentation standards:
https://www.fda.gov/medical-devices/in-vitro-diagnostics

NIH validation guidance for diagnostic assays:
https://www.ncbi.nlm.nih.gov/books/NBK305/

Research and Surveillance Applications

The Dog Rabies Antigen Rapid Test Card supports:

  • Field surveillance programs

  • Veterinary clinic screening

  • Animal control monitoring

  • Wildlife reservoir assessment

  • Academic research studies

USDA wildlife rabies management program:
https://www.aphis.usda.gov/aphis/ourfocus/wildlifedamage/programs/nwrc/research/rabies

EPA zoonotic disease environmental considerations:
https://www.epa.gov/emergency-response/rabies

Conclusion

The Dog Rabies Antigen Rapid Test Card is a technically robust immunochromatographic diagnostic tool for rapid detection of rabies virus antigen in canine samples. Its lateral flow design allows rapid qualitative screening in veterinary and field settings, supporting structured surveillance systems.